Signal validation
Determine whether the information supports formal signal assessment, known-risk handling, or continued surveillance.
Validation questions
Select the statements supported by the available information.
Complete the validation questions to generate a transparent recommendation.
Not evaluated- Document the information source and data cut
- Record the decision and supporting rationale
Signal prioritization
Score five domains against written anchors, 1 to 5 each, for a total out of 25. Prioritization allocates assessment capacity. A signal placed in a lower band has not been judged less likely to be real; it has been judged able to wait longer for the same assessment.
Score each domain against its anchors
Anchors are defined at 1, 3 and 5. Scores of 2 and 4 are permitted and denote a position between the adjacent anchors, which the rationale must explain. Score the domains before looking at the total, and write each rationale in the language of the evidence rather than the language of the conclusion.
Clinical override
The committee may assign a band different from the one the total indicates, in either direction. An override is a recorded decision, not a correction of the arithmetic, and the reason is mandatory. Repeated overrides of the same kind mean the anchors need revision rather than repeated correction by hand.
Score the five domains to produce a total out of 25, a band, and an illustrative internal target to start assessment.
Not evaluated| Domain | Score | Rationale |
|---|---|---|
| Not scored | ||
The plot shows two of the five domains. The band comes from the total of all five, and the override comes from the committee.
Disproportionality calculator
Calculate PRR and ROR with confidence intervals, the expected count, the Information Component with its lower credibility bound, and Pearson chi-square from a 2×2 spontaneous-report table.
Enter report counts
Use mutually exclusive counts from the same database and data lock.
A disproportionality measure quantifies a reporting pattern within one database. It is not a measure of risk, not an incidence, and not a statement of comparative safety between products.
Whether a continuity correction was applied is reported here once the measures are calculated.
Not evaluatedObserved to expected
Compare an observed count inside a predefined risk window against the count expected from an external background rate, with an exact Poisson interval and an explicit background-rate sensitivity range.
Exposure, risk window, and background rate
Person-time = exposed × window ÷ 365.25. Expected = rate ÷ unit denominator × person-time.
Background-rate sensitivity
The crude ratio is the first line of a sensitivity analysis, not its conclusion. Enter the published range for the background rate.
Enter exposure, risk window, background rate, and the observed count. Quote the range the assumptions produce, not a single ratio.
Background-rate sensitivity
| Scenario | Expected | O/E |
|---|---|---|
| Not calculated | ||
Time to onset
Summarize reported onset intervals as median, interquartile range, and range, and show the shape of the distribution rather than a single number.
Onset intervals
One value per assessable case, in days from the start of the exposure clock. Separate values with commas, spaces, or new lines.
Quartiles are calculated by the Tukey-halves method, stated because conventions differ.
Evidence integration
Give each stream the weight its validity for this question earns, and record why. No generic hierarchy is applied and nothing is summed: a randomized trial is not automatically superior for a rare delayed event, and a large database is not superior when its outcome definition does not identify the clinical entity.
The question the sources are weighted against
Four attributes of the question decide which sources can carry weight: frequency, latency, ascertainment, and confounding structure. Fix them before assigning any weight.
Evidence streams
One entry per stream, including those examined and found unhelpful: a stream absent from the table is indistinguishable from one nobody looked at. The weight cannot be left blank, and the justification must reference validity for this question rather than volume. No weight is what a source receives when its design cannot address the question, and it is a different entry from a source that addresses the question and points the other way.
Triangulation
Confidence rises when sources whose biases run in different directions point to the same clinical association. Four sources sharing a bias have not triangulated anything, and independence must be checked rather than assumed.
Discordance
When two sources disagree, the disagreement is information about how one of them was constructed. Averaging destroys that information. Name the axis that would explain the conflict and test it.
Each stream receives a direction and an explicit weight with its reason. The table is the output; there is no total.
Not evaluated| Source and finding | Direction, weight, and reason |
|---|---|
| No entries yet | |
- Fix the question before weighting any source
- Record why each weight was given, for this question
- Check triangulation and name any discordance axis
Causality structure
The Bradford Hill considerations organize an aggregate causal argument so a reader can see what was examined and what was found. They are not criteria to be met, not a checklist, and not a scale. Aggregate causality asks whether the product causes the event in the exposed population; it is a different question from whether this drug caused this patient’s event, and the answer to one does not aggregate into the answer to the other.
Considerations
For each consideration, record what the evidence shows and the caution that attaches to it. A consideration with nothing to show is a finding and belongs here rather than in the reviewer’s memory.
Closing the argument
Complete these in order. The field for evidence opposing the association is not optional: an argument with it empty has either been written backward or has not looked.
Each consideration is recorded with the caution that attaches to it. The output is an argument a reader can audit, not a category.
Not evaluated| Consideration | What the evidence shows, and the caution |
|---|---|
| No entries yet | |
- Name the consideration the mechanism predicts will be informative
- Write the opposing evidence before the inference
- Keep the inference in causal-claim vocabulary
Benefit–risk integration
Given a newly characterized risk, does the balance remain favorable in the population and conditions of use currently authorized, and where it does not, for whom and under what conditions does it fail? The second half of that question does most of the work, because it separates a proportionate action from a blunt one.
Favorable and unfavorable effects
State absolute magnitude per 10,000 treated over a stated period, not a relative risk reduction, and give the benefit estimate the same fields as the risk estimate: source, population, magnitude, time period, uncertainty. The risk is examined by a team that knows every weakness of its own estimate; the benefit is too often lifted from a label and enters without an interval.
Favorable effects
Unfavorable effects
Clinical context and value judgment
Subgroup decomposition
The overall balance can remain favorable while it turns unfavorable for a definable subgroup, a dose, a combination, or a setting of use. Show the arithmetic of the restriction explicitly: how much benefit is forgone by removing the subgroup from treatment, and how much harm goes with it.
The effects table and the decomposition are the output. No single margin number is produced, because no single number carries severity, reversibility, or who bears the outcome.
Not evaluatedDecomposition by susceptibility
Enter the population, the outcomes prevented, the harms caused, and the susceptible subgroup with its share of the harms.
Effects recorded
| Effect | Estimate, evidence, importance, uncertainty, subgroup |
|---|---|
| No entries yet | |
Proportionate action ladder
Decision record
Create a reconstruction-ready record linking the evidence, uncertainty, conclusion, action, ownership, and reopening criteria.
Required fields will be checked for completeness.
Incomplete- Source and data cut
- Methods, findings, and limitations
- Decision, rationale, dissent, and approvals
- Action owner, due date, and follow-up
Signal assessment summary
A concise decision view assembled from the assessment modules. Review and edit the formal source documents before approval.
Generated assessment record
Copy, download, or print this structured draft for review.
The full assessment adds every module input as entered, the scenario-laboratory trail, and the standing caveats, as plain text ready to paste into an assessment report.
Real-world signal scenarios
Work through incomplete evidence, make decisions at realistic checkpoints, and compare your reasoning with an expert approach.
Torvaxel: delayed drug-induced liver injury
An oral small molecule whose label carries no hepatotoxicity warning generates an unexpected serious hepatic report.
Initial alert
Expert debrief
The record captures what you decided with the information available at each stage.
About this tool
A working companion to the book, built to be used on a real assessment and explicit about what it is not.
Signal Management in Pharmacovigilance
From Detection and Validation to Benefit–Risk Decisions and Regulatory Action
This decision-support tool is the companion to Signal Management in Pharmacovigilance: From Detection and Validation to Benefit–Risk Decisions and Regulatory Action, by Dr. Hafez Selim, MD, PhD, published by Selim Medical Press. The nine modules follow the book’s decision pathway from validation to the decision record, and the scenario laboratory works three of the book’s cases.
Everything typed into this page stays in this browser tab. The page itself stores nothing, makes no network request of its own, and closing or reloading it discards every entry. One surface is not covered by that: if you read this page in a browser whose AI assistant supports the Web Model Context API, this page offers that assistant read access to the assessment summary you have entered, and a cloud-backed assistant would take that content off this machine. Copy, download or print an assessment before you leave if it is to be kept.
No storage · no transmission- The page itself sends nothing anywhere
- An AI browser assistant supporting the Web Model Context API can read the summary entered
- No cookies, no local storage, no analytics, no account
- No external scripts, fonts, images or network requests
- Closing the page discards everything
Currency
Last reviewed September 2026. Regulatory content — procedure names, database names, guidance versions and timelines — should be re-checked against current guidance before it is relied on, because it changes between printings.